Navigation Links
Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
Date:8/26/2010

reatment OptionsADHF is the leading diagnosis at the time of discharge from U.S. hospitals and the most common cause of hospitalization for patients over 65 years of age.(i) Well over $39 billion was spent in the U.S. in 2009 for the medical care of heart failure patients. ADHF is a deadly condition, with in-hospital mortality rates of two to six percent and six-month readmission rates as high as 30 to 60 percent.  Episodes of ADHF are marked by a severe reduction of cardiac function that typically results in fluid accumulation in the lungs (pulmonary edema) and consequent severe shortness of breath.  There were 1.1 million hospitalizations for acute heart failure in the U.S. in 2006.  Among patients hospitalized with ADHF, the 30-day mortality rate is approximately 11 percent and the one-year mortality rate is 34 percent.  These poor outcomes indicate the clear need for better therapies to treat this patient population.

Despite the severity of the condition, the treatment options available for patients with ADHF remain limited.  Current first-line treatments target the removal of excess fluid (diuresis) and preload and afterload reduction (vasodilation).  In order to improve the hemodynamic profile of the heart and increase cardiac contractility, a physician may also administer an intravenous inotropic agent such as dobutamine (beta-adrenergic agonist) or milrinone (PDE3-inhibitor).  Administration of dobutamine or milrinone often requires very close monitoring in the hospital's cardiac or intensive care unit setting due to the life-threatening safety risks associated with these drugs, including ventricular/atrial arrhythmias, hypotension, sudden cardiac death, and other potential adverse long term outcomes.(ii),(iii)

About Cardioxyl Pharmaceuticals Cardioxyl Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery and development of new classes of safe and effective therapeutic agents f
'/>"/>

SOURCE Cardioxyl Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lotus Pharmaceuticals Enter R-Bambuterol(R) Clinical Trial I
2. Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
3. Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension
4. China Yongxin Pharmaceuticals Reports Second Quarter 2010 Results
5. Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia
6. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
7. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
8. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
9. Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
10. Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
11. Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down methamphetamine offenders and make arrests. Data released ... Michigan blocked the sale of more ...
(Date:8/20/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Personal Accident and ... Opportunities to 2018 ... provides in depth market analysis, information and ... health insurance segment, including: - The French ...
(Date:8/20/2014)... , Aug. 20, 2014 ... of the "Global Biosimilars/Follow-on-Biologics Market (Technology, Types, ... - 2020" report to their offering. ... market (types, applications and geography) - Size, Share, ... Report, Opportunities, Segmentation and Forecast, 2013 - 2020", ...
Breaking Medicine Technology:Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2
... XI,AN, China , ... (OTC Bulletin Board: HFGB), specializing,in developing and producing ... food additives, today announced the receipt of its,European ... from Galenicum,Health S.L., a Spanish pharmaceutical company. This ...
... DIEGO , July 22 MabVax Therapeutics Inc., ... development of vaccine and antibody based therapies to address the ... first patients have been enrolled in a Phase II clinical ... vaccine to prevent or delay the recurrence of sarcoma. The ...
Cached Medicine Technology:Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order 2Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order 3MabVax Therapeutics Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma 2MabVax Therapeutics Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma 3
(Date:8/20/2014)... 21, 2014 Top10BestSEOHosting.com is a ... about hosting products. It is headed by a ... The site offers research-based information and factual studies ... in the current market. , Recently, Top10BestSEOHosting.com ... that GoDaddy and Bluehost are the ...
(Date:8/20/2014)... City, UT (PRWEB) August 20, 2014 ... Benefits Solution, announced the publication of a new ... Zane Benefits, many small business owners feel uncertain ... employees, their family, and their bottom line. , ... comprehensive FAQs, and helps businesses navigate their upcoming ...
(Date:8/20/2014)... (HealthDay News) -- A group representing U.S. obstetricians is ... shot. According to the American College of Obstetricians ... have upheld the safety and effectiveness of flu vaccination ... and can be particularly dangerous to pregnant women, as ... Dr. Laura Riley, chair of the college,s Immunization Expert ...
(Date:8/20/2014)... of women underwent breast reconstruction following a mastectomy ... reconstruction included being black, having a lower education ... M.D., of the Memorial Sloan Kettering Cancer Center, ... Health and Cancer Rights Act in 1998 guaranteed ... Still, most women who undergo a mastectomy do ...
(Date:8/20/2014)... August 20, 2014 Hundreds of Mirena ... of women who were allegedly injured due to spontaneous ... New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP ... August 15, 2014, the Court has established procedures regarding ... lawsuits that are part of the proceeding’s initial disposition ...
Breaking Medicine News(10 mins):Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4
... said that people were offered places in hotels it was ... defending their decision to house hospital patients in Aberdeen hotel ... Grampian said a doctor always took the decision as to ... outwith the city's Royal Infirmary. She said that as the ...
... is a fungal infection affecting mostly children in North America. ... affected by ringworm infections. //It is a highly contagious skin ... symptoms such as scaly scalp and hair loss which can ... household pets but in rare occasions it is passed easily ...
... the poor quality of drinking water for the cholera cases ... 222 cases have been reported.// ,"The capital has reported ... last year. But we are not triggering the warning bell ... deputy municipal health officer of Delhi. ,"Waterborne diseases ...
... in New Zealand have warned against using traditional Indian ... it was reported Friday.// ,"We wish to alert ... posed by a particular form of herbal remedy, namely, ... latest New Zealand Medical Journal. ,The eight ...
... Court has demanded an explanation from the medical superintendent (MS) ... from cancer got inflicted with AIDS after undergoing blood transfusion ... on why the relevant documents were not being made available ... that the blood transfusion was the business of the public ...
... of an influenza pandemic set into action by mutations of the ... handle// a mega crisis, and what plan of action can we ... an epidemic, eight Asia Pacific countries are teaming up next month ... of a global response to a pandemic. ,Australia and ...
Cached Medicine News:
... The first step to treatment is accurate ... an innovative and quick, patient-friendly tool designed ... urinary incontinence while minimizing patient discomfort. Designed ... features a new type of urethral pressure ...
...
...
...
Medicine Products: